首页 工具
登录

搜索结果

Search Results for "FTISADTSK"

如果没找到您满意的产品或者您对产品有其他要求,可以联系我们专业顾问为您提供针对性的合理建议。     QQ咨询       网站留言咨询

提交您的定制咨询

Cat. No. Product Name Target Signaling Pathways
T38907 FTISADTSK

FTISADTSK is an endogenous stable signature peptide from Trastuzumab monitored by selected reaction monitoring (SRM).
T38023 FTISADTSK acetate

FTISADTSK acetate is an endogenous stable signature peptide from Trastuzumab monitored by selected reaction monitoring (SRM)[1]. [1]. Bults P, et al. LC-MS/MS-Based Monitoring of In Vivo Protein Biotransformation: Quantitative Determination of Trastuzumab and Its Deamidation Products in Human Plasma. Anal Chem. 2016;88(3):1871-1877.

化合物

FTISADTSK
T38907
synonym:
Target:
FTISADTSK acetate
T38023
synonym:
Target: